Cargando…

Role of the PD‐1/PD‐L1 Signaling in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Recent Insights and Future Directions

Multiple sclerosis (MS) is an autoimmunity-related chronic demyelination disease of the central nervous system (CNS), causing young disability. Currently, highly specific immunotherapies for MS are still lacking. Programmed cell death 1 (PD-1) is an immunosuppressive co-stimulatory molecule, which i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mi, Yan, Han, Jinming, Zhu, Jie, Jin, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639577/ https://www.ncbi.nlm.nih.gov/pubmed/34480337 http://dx.doi.org/10.1007/s12035-021-02495-7

Ejemplares similares

Cerebellar pathology in multiple sclerosis and experimental autoimmune encephalomyelitis: current status and future directions
por: Maxwell, Dain L., et al.
Publicado: (2023)

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Girolamo, Francesco, et al.
Publicado: (2014)

Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune Encephalomyelitis
por: Salama, Alan D., et al.
Publicado: (2003)

Orexin/hypocretinin in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Pallais, Jean Pierre, et al.
Publicado: (2019)

Editorial: Pain in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Lovett-Racke, Amy, et al.
Publicado: (2022)

PD-1/PD-L1 Axis as a Potential Therapeutic Target for Multiple Sclerosis: A T Cell Perspective
por: Li, HaiXia, et al.
Publicado: (2021)

Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives
por: Chu, Fengna, et al.
Publicado: (2018)

Dietary Modulation of Intestinal Microbiota: Future Opportunities in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Fan, Yuying, et al.
Publicado: (2019)

Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Costanza, Massimo, et al.
Publicado: (2012)

Relapsing experimental allergic encephalomyelitis an autoimmune model of multiple sclerosis
por: Lublin, Fred D.
Publicado: (1985)

PD‐1 expression is upregulated on adapted T cells in experimental autoimmune encephalomyelitis but is not required to maintain a hyporesponsive state
por: Mair, Iris, et al.
Publicado: (2018)

PD-L1 is increased in the spinal cord and infiltrating lymphocytes in experimental allergic encephalomyelitis
por: Li, Min, et al.
Publicado: (2013)

High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions
por: Allouch, Soumaya, et al.
Publicado: (2020)

Molecular Mechanisms of Oligodendrocyte Injury in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Patel, Jilpa, et al.
Publicado: (2012)

Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Clemente, Nausicaa, et al.
Publicado: (2017)

Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Dhaiban, Sarah, et al.
Publicado: (2020)

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
por: Yi, Ming, et al.
Publicado: (2022)

Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Kleiter, Ingo, et al.
Publicado: (2010)

The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Aarts, Suzanne A. B. M., et al.
Publicado: (2017)

Mechanism of experimental autoimmune encephalomyelitis in Lewis rats: recent insights from macrophages
por: Shin, Taekyun, et al.
Publicado: (2012)

Current Landscape and Future Direction of PD-1/PD-L1 Checkpoint Inhibitors in Cancer Treatment
por: Serratì, Simona, et al.
Publicado: (2023)

PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases
por: Zhang, Ke, et al.
Publicado: (2022)

Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis
por: Cunningham, Timothy J, et al.
Publicado: (2006)

The Contribution of Immune and Glial Cell Types in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Duffy, Samuel S., et al.
Publicado: (2014)

Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Arellano, Gabriel, et al.
Publicado: (2015)

Celastrol Attenuates Multiple Sclerosis and Optic Neuritis in an Experimental Autoimmune Encephalomyelitis Model
por: Yang, Hongbin, et al.
Publicado: (2017)

Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
por: Johnson, Thomas W., et al.
Publicado: (2016)

Systemic Acrolein Elevations in Mice With Experimental Autoimmune Encephalomyelitis and Patients With Multiple Sclerosis
por: Tully, Melissa, et al.
Publicado: (2018)

Role of nuclear factor κB in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Yue, Yuan, et al.
Publicado: (2018)

Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Quinn, James L., et al.
Publicado: (2018)

The Short and Long-Term Effects of Pregnancy on Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: McCombe, Pamela A
Publicado: (2018)

Assessment of Mitochondrial Dysfunction in Experimental Autoimmune Encephalomyelitis (EAE) Models of Multiple Sclerosis
por: Ng, Xiulin, et al.
Publicado: (2019)

Neuronal and endothelial transglutaminase-2 expression in experimental autoimmune encephalomyelitis and multiple sclerosis
por: Pearse, Damien D., et al.
Publicado: (2021)

Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction
por: Boziki, Marina, et al.
Publicado: (2023)

SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges
por: Chen, Yu, et al.
Publicado: (2020)

Translational utility of experimental autoimmune encephalomyelitis: recent developments
por: Guerreiro-Cacais, Andre Ortlieb, et al.
Publicado: (2015)

Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis
por: Schmitz, K., et al.
Publicado: (2017)

PD-1/PD-L Axis in Neuroinflammation: New Insights
por: Manenti, Susanna, et al.
Publicado: (2022)

Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
por: Noorbakhsh, Farshid, et al.
Publicado: (2006)

The Immune-Modulatory Role of Apolipoprotein E with Emphasis on Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Zhang, Hong-Liang, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_bhnsiu09r8lr9042c3v87ae9n3